Clinical Trials Logo

Clinical Trial Summary

The purpose of this study was to investigate various potential factors that affected the outcome of treatment of congenital nasolacrimal duct obstruction.


Clinical Trial Description

Congenital nasolacrimal duct obstruction is a common condition during the first few years of childhood. Most cases may resolve spontaneously, but the remaining children whose blockage does not resolve may require primary probing. Controversy remains regarding the optimal timing of the probing procedure. Another controversy is related to the setting of surgery. Therefore, we try to investigate the factors that affected the outcome of treatment of congenital nasolacrimal duct obstruction under the same surgical doctor during the past 13 years in our hospital. ;


Study Design

Observational Model: Cohort, Time Perspective: Retrospective


Related Conditions & MeSH terms

  • Congenital Nasolacrimal Duct Obstruction

NCT number NCT02081781
Study type Observational
Source Cathay General Hospital
Contact
Status Completed
Phase N/A
Start date February 2014
Completion date March 2014

See also
  Status Clinical Trial Phase
Completed NCT01431170 - Safety and Efficacy Study of Besivanceā„¢ for Treatment of Congenital Nasolacrimal Duct Obstruction in Children Phase 1
Recruiting NCT04148170 - Recanalization of Congenital Nasolacrimal Duct Obstruction by Endodiathermy Probe and Intubation Versus Intubation Only Phase 2/Phase 3
Active, not recruiting NCT03242681 - Endoscopy Assisted Probing Versus Simple Probing in Primary Congenital Nasolacrimal Duct Obstruction N/A